4431.TWO Mytrex Health Technologies, Inc.
- Market cap
- TWD 756M
- P/E
- -
- P/B
- 1.31x
- ROE
- -2.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is 4431.TWO undervalued?
Graham numberThe Graham number of Mytrex Health Technologies, Inc. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Mytrex Health Technologies, Inc. fundamental analysis
No fundamental analysis for Mytrex Health Technologies, Inc. yet.
Mytrex Health Technologies, Inc. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Mytrex Health Technologies, Inc.
Mytrex Health Technologies, Inc. engages in the manufacturing, processing, and sale of various filter non-woven fabrics in Taiwan, rest of Asia, Europe, and internationally. The company provides electrostatic filtration materials for medical and industrial mask media, and other filtration applications; and composite nonwoven products for coolant and air filter, vacuum filter bag, HEPA and cabin filter, and water filtration compound material applications. It also offers therm…
Full company profileMytrex Health Technologies, Inc. financial statements
Mytrex Health Technologies, Inc. annual financial statements (TWD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 398M | 1.02B | 292M | 1.47B | 1.29B | 1.76B | 1.94B |
| Gross Profit | 60.9M | 629M | 40.1M | 239M | 192M | 222M | 243M |
| Operating Income | 5.43M | 438M | -15.5M | -51.9M | -78.0M | -76.9M | -18.0M |
| EBITDA | 21.0M | 472M | 35.1M | 49.9M | 7.63M | 17.3M | 57.3M |
| Net Income | 9.32M | 352M | -14.0M | -91.9M | -56.2M | -82.4M | -16.6M |
| EPS | 0.29 | 11 | -0.38 | -2.52 | -1.54 | -2.25 | -0.45 |
| Balance Sheet | |||||||
| Total Assets | 407M | 1.33B | 954M | 1.49B | 1.26B | 1.15B | 1.18B |
| Total Liabilities | 73.8M | 351M | 119M | 520M | 581M | 536M | 598M |
| Shareholders' Equity | 333M | 972M | 834M | 965M | 675M | 600M | 585M |
| Cash & Short-term Investments | 150M | 760M | 471M | 487M | 241M | 278M | 301M |
| Total Debt | 30.8M | 174M | 56.9M | 332M | 326M | 226M | - |
| Cash Flow | |||||||
| Operating Cash Flow | 59.9M | 441M | 13.3M | 72.5M | -4.26M | 31.6M | 201M |
| Capital Expenditure | 9.66M | 189M | 30.3M | 43.3M | 25.0M | 15.0M | 5.83M |
| Free Cash Flow | 50.3M | 251M | -17.0M | 29.2M | -29.3M | 16.6M | 195M |
| Ratios | |||||||
| ROE | 2.8% | 36.2% | -1.7% | -9.5% | -8.3% | -13.7% | -2.8% |
| ROA | 2.3% | 26.6% | -1.5% | -6.2% | -4.5% | -7.2% | -1.4% |
| Net Profit Margin | 2.3% | 34.4% | -4.8% | -6.2% | -4.3% | -4.7% | -0.9% |
| Debt to Equity | 0.09x | 0.18x | 0.07x | 0.34x | 0.48x | 0.38x | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Mytrex Health Technologies, Inc. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Sep 14, 2021
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | TWD 122M | 3.33 | - |
| 2020 | 4.13M | 0.13 | 1.2% |
| 2019 | 5.04M | 0.16 | 54.0% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1500:1000 on Sep 14, 2021.
Who owns Mytrex Health Technologies, Inc.
Ownership data of Mytrex Health Technologies, Inc. is not available yet.
Mytrex Health Technologies, Inc. company profile
- Company name
- Mytrex Health Technologies, Inc.
- Ticker
- 4431.TWO
- ISIN
- TW0004431002
- Exchange
- Taiwan OTC Exchange
- Sector
- Industrials
- Industry
- Specialty Industrial Machinery
- Fiscal year end
- December
- Address
- No. 545, Hezun North Road, Taoyuan City, Taiwan, 320020
- Phone
- 886 3 463 1317
- Website
- mytrex.com.tw
About Mytrex Health Technologies, Inc.
Mytrex Health Technologies, Inc. engages in the manufacturing, processing, and sale of various filter non-woven fabrics in Taiwan, rest of Asia, Europe, and internationally. The company provides electrostatic filtration materials for medical and industrial mask media, and other filtration applications; and composite nonwoven products for coolant and air filter, vacuum filter bag, HEPA and cabin filter, and water filtration compound material applications. It also offers thermal insulation products for glove, sock, shoe, hat, clothing material, and mask insulation material applications; and linen laundry and leasing, logistic, and medical supplies for hospitals. In addition, the company sells pharmaceuticals and medical hygiene materials; and manages medical clothing products. Mytrex Health Technologies, Inc. was founded in 1990 and is based in Taoyuan City, Taiwan.
Mytrex Health Technologies, Inc. management
5- Mr. Charles ChangGeneral Manager and Director
- Mr. Hung-Jen YangChairman & CEO · born 1969
- Mr. Sy-Ming GuuPresident
- Zi Wen WeiChief Financial Officer and Chief Accounting Officer
- Jia Lin ChenResearch & Development Department Manager and Sales Manager